We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+6.97%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$17.9B
AUM Growth
+$3.18B
Cap. Flow
+$2.11B
Cap. Flow %
11.82%
Top 10 Hldgs %
38.29%
Holding
721
New
293
Increased
98
Reduced
124
Closed
140

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$124M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$95.2M
3
PLRX icon
Pliant Therapeutics
PLRX
+$74.8M
4
MSFT icon
Microsoft
MSFT
+$72.6M
5
BMY icon
Bristol-Myers Squibb
BMY
+$56.6M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$123M
2
CTLT
CATALENT, INC.
CTLT
+$60.4M
3
EMR icon
Emerson Electric
EMR
+$55M
4
HD icon
Home Depot
HD
+$54.8M
5
CMCSA icon
Comcast
CMCSA
+$53.9M

Sector Composition

Rank Sector Weight
1 Healthcare 5.44%
2 Technology 2.51%
3 Communication Services 1.69%
4 Utilities 1.38%
5 Industrials 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMG icon
201
PUT
Chipotle Mexican Grill
CMG
$41.5B
$12.2M 0.07%
+285,000
New +$11.3M
XHB icon
202
PUT
State Street SPDR S&P Homebuilders ETF
XHB
$1.56B
$12M 0.07%
+150,000
New +$10.7M
HON icon
203
CALL
Honeywell
HON
$78B
$12M 0.07%
+61,326
New +$11.4M
PCG icon
204
PG&E
PCG
$38.5B
$12M 0.07%
693,245
+136,287
+24% +$2.31M
MRVL icon
205
Marvell Technology
MRVL
$196B
$12M 0.07%
200,000
+157,035
+365% +$7.63M
MLYS icon
206
Mineralys Therapeutics
MLYS
$2.41B
$11.6M 0.06%
680,131
+4,995
+0.7% +$74.7K
LVS icon
207
PUT
Las Vegas Sands
LVS
$29.6B
$11.5M 0.06%
+197,500
New +$11.7M
FOXA icon
208
CALL
Fox Class A
FOXA
$26.9B
$11.2M 0.06%
330,000
– –
FOXA icon
209
PUT
Fox Class A
FOXA
$26.9B
$11.2M 0.06%
330,000
– –
ISRG icon
210
CALL
Intuitive Surgical
ISRG
$134B
$11M 0.06%
32,300
-207,700
-87% -$62.8M
MELI icon
211
Mercado Libre
MELI
$92.3B
$10.9M 0.06%
+9,218
New +$11.6M
KVUE icon
212
Kenvue
KVUE
$36.9B
$10.9M 0.06%
+411,052
New +$10.7M
LOW icon
213
PUT
Lowe's Companies
LOW
$125B
$10.8M 0.06%
47,900
-56,500
-54% -$11.8M
CRWD icon
214
CALL
CrowdStrike
CRWD
$218B
$10.1M 0.06%
+275,200
New +$9.59M
SWTX
215
DELISTED
SpringWorks Therapeutics
SWTX
$9.94M 0.06%
379,064
-18,632
-5% -$490K
VOR icon
216
Vor Biopharma
VOR
$1.28B
$9.84M 0.06%
159,144
– –
UBER icon
217
PUT
Uber
UBER
$153B
$9.8M 0.05%
+226,900
New +$8.43M
WBD icon
218
CALL
Warner Bros
WBD
$67.1B
$9.4M 0.05%
+749,800
New +$9.73M
WBD icon
219
PUT
Warner Bros
WBD
$67.1B
$9.4M 0.05%
+749,800
New +$9.73M
SGEN
220
DELISTED
Seagen Inc. Common Stock
SGEN
$9.31M 0.05%
+48,399
New +$9.62M
ALGN icon
221
CALL
Align Technology
ALGN
$12.3B
$9.19M 0.05%
+26,000
New +$8.28M
DIS icon
222
CALL
Walt Disney
DIS
$181B
$8.86M 0.05%
99,200
-270,400
-73% -$25.6M
SBUX icon
223
PUT
Starbucks
SBUX
$120B
$8.47M 0.05%
85,500
-833,100
-91% -$86.5M
TGT icon
224
PUT
Target
TGT
$68B
$8.42M 0.05%
63,800
-47,400
-43% -$7.03M
ALDX icon
225
Aldeyra Therapeutics
ALDX
$93.5M
$8.4M 0.05%
1,001,377
+44,477
+5% +$438K
7 8
9
10 11

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

Laurion Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Laurion Capital Management held 721 positions worth $17.9B, up 22% from $14.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Laurion Capital Management deployed $2.11B of net new capital in Q2 2023, opening 293 new positions and adding to 98 existing holdings. Its largest new stake was Pliant Therapeutics: 3,158,570 shares worth $57.2M.

By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, down from 6.6% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Viatris, an estimated $123M trimmed.

  • Laurion Capital Management's largest Q2 2023 buy was Pliant Therapeutics: 3,158,570 shares worth $57.2M.
  • Laurion Capital Management added most to T-Mobile US in Q2 2023, an estimated $124M increase.
  • Laurion Capital Management's biggest Q2 2023 reduction was Viatris, cutting an estimated $123M.
  • Laurion Capital Management fully exited CATALENT, INC. in Q2 2023, selling an estimated $60.4M.
  • Laurion Capital Management's ten largest holdings make up 38% of its $17.9B portfolio in Q2 2023.
  • Laurion Capital Management opened 293 new positions and closed 140 in Q2 2023.
  • Laurion Capital Management's portfolio value rose 22% quarter-over-quarter to $17.9B.

Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.